Search Results - "Shibusawa, Motoharu"

Bortezomib Use for a Critically Ill Patient with Angioimmunoblastic T-Cell Lymphoma by Shibusawa, Motoharu

“…Angioimmunoblastic T-cell lymphoma (AITL) accounts for 18.5% of all peripheral T-cell lymphomas. There is still no gold standard chemotherapy for treating…”
Get full text

Acute Myelogenous Leukemia with the t(7;7)(p15;p22) Translocation, a Novel Simple Variant of t(7;11)(p15;p15) Translocation: First Description by Shibusawa, Motoharu

“…The t(7;11)(p15;p15) translocation is a recurrent genetic abnormality associated with acute myelogenous leukemia (AML). The translocation results in a fusion…”
Get full text

A critical appraisal of Japan's new drug approval process: a case study of FLT3-ITD inhibitor quizartinib by Kidoguch, Keisuke, Shibusawa, Motoharu, Tanimoto, Tetsuya

“…In the last two decades, simultaneous global development of novel drugs become more common by conducting multiregional clinical trials. However, regulatory…”
Get full text

Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia by Wakita, Satoshi, Marumo, Atsushi, Morita, Kaoru, Kako, Shinichi, Toya, Takashi, Najima, Yuho, Doki, Noriko, Kanda, Junya, Kuroda, Junya, Mori, Shinichiro, Satake, Atsushi, Usuki, Kensuke, Ueki, Toshimitsu, Uoshima, Nobuhiko, Kobayashi, Yutaka, Kawata, Eri, Nakayama, Kazutaka, Nagao, Yuhei, Shono, Katsuhiro, Shibusawa, Motoharu, Tadokoro, Jiro, Hagihara, Masao, Uchiyama, Hitoji, Uchida, Naoyuki, Kubota, Yasushi, Kimura, Shinya, Nagoshi, Hisao, Ichinohe, Tatsuo, Kurosawa, Saiko, Motomura, Sayuri, Hashimoto, Akiko, Muto, Hideharu, Sato, Eriko, Ogata, Masao, Mitsuhashi, Kenjiro, Ando, Jun, Tashiro, Haruko, Sakaguchi, Masahiro, Yui, Shunsuke, Arai, Kunihito, Kitano, Tomoaki, Miyata, Miho, Arai, Haruka, Kanda, Masayuki, Itabashi, Kako, Fukuda, Takahiro, Kanda, Yoshinobu, Yamaguchi, Hiroki

“…Nucleophosmin1 (NPM1) mutations are the most frequently detected gene mutations in acute myeloid leukemia (AML) and are considered a favorable prognostic…”
Get full text

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia by Wakita, Satoshi, Sakaguchi, Masahiro, Oh, Iekuni, Kako, Shinichi, Toya, Takashi, Najima, Yuho, Doki, Noriko, Kanda, Junya, Kuroda, Junya, Mori, Shinichiro, Satake, Atsushi, Usuki, Kensuke, Ueki, Toshimitsu, Uoshima, Nobuhiko, Kobayashi, Yutaka, Kawata, Eri, Tajika, Kenji, Nagao, Yuhei, Shono, Katsuhiro, Shibusawa, Motoharu, Tadokoro, Jiro, Kayamori, Kensuke, Hagihara, Masao, Uchiyama, Hitoji, Uchida, Naoyuki, Kubota, Yasushi, Kimura, Shinya, Nagoshi, Hisao, Ichinohe, Tatsuo, Kurosawa, Saiko, Motomura, Sayuri, Hashimoto, Akiko, Muto, Hideharu, Sato, Eriko, Ogata, Masao, Mitsuhashi, Kenjiro, Ando, Jun, Marumo, Atsushi, Omori, Ikuko, Fujiwara, Yusuke, Terada, Kazuki, Yui, Shunsuke, Arai, Kunihito, Kitano, Tomoaki, Miyata, Miho, Kurosawa, Akiyo, Mizoguchi, Ayumi, Komatsu, Norio, Fukuda, Takahiro, Ohashi, Kazuteru, Kanda, Yoshinobu, Inokuchi, Koiti, Yamaguchi, Hiroki

“…Mutations of CCAAT/enhancer–binding protein alpha (CEBPAmu) are found in 10% to 15% of de novo acute myeloid leukemia (AML) cases. Double-mutated CEBPA…”
Get full text

NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia by Marumo, Atsushi, Wakita, Satoshi, Morita, Kaoru, Oh, Iekuni, Kako, Shinichi, Toya, Takashi, Najima, Yuho, Doki, Noriko, Kanda, Junya, Kuroda, Junya, Mori, Shinichiro, Satake, Atsushi, Usuki, Kensuke, Uoshima, Nobuhiko, Kobayashi, Yutaka, Kawata, Eri, Nagao, Yuhei, Shono, Katsuhiro, Shibusawa, Motoharu, Tadokoro, Jiro, Hagihara, Masao, Uchiyama, Hitoji, Kubota, Yasushi, Kimura, Shinya, Motomura, Sayuri, Hashimoto, Akiko, Muto, Hideharu, Sato, Eriko, Ogata, Masao, Mitsuhashi, Kenjiro, Ando, Jun, Date, Kenta, Fujiwara, Yusuke, Terada, Kazuki, Yui, Shunsuke, Arai, Kunihito, Kitano, Tomoaki, Miyata, Miho, Ohashi, Kazuteru, Kanda, Yoshinobu, Yamaguchi, Hiroki

“…Recent studies have reported that measurable residual disease (MRD) analysis using NPM1 mutations helps determine whether allogeneic hematopoietic stem cell…”
Get full text

Varicella Infection Complicated by Marked Thrombocytopenia by Shibusawa, Motoharu, Motomura, Sayuri, Hidai, Hiroko, Tsutsumi, Hisasi, Fujita, Akira

“…We report a rare case of adult varicella complicated by marked thrombocytopenia. A 49-year-old woman presented with fever and rash for 3 days. Blood…”
Get full text

Ruxolitinib for Chronic Graft-versus-Host Disease by Shibusawa, Motoharu

Get full text

Conditioning Regimen in Patients With Adult Acute B Lymphoblastic Leukemia by Shibusawa, Motoharu, Tanimoto, Tetsuya

Get full text

Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies by Shibusawa, Motoharu, Tanimoto, Tetsuya

Get full text

Multiple myeloma triplet therapies: baseline characteristics and control groups by Shibusawa, Motoharu, Tanimoto, Tetsuya

Get full text

Plasma cell leukaemia presenting as flower-shaped plasma cells mimicking adult T-cell leukaemia or lymphoma by Shibusawa, Motoharu

Get full text

Acute Myelogenous Leukemia with the t Translocation: First Description by Shibusawa, Motoharu

“…The t(7;11)(p15;p15) translocation is a recurrent genetic abnormality associated with acute myelogenous leukemia (AML). The translocation results in a fusion…”
Get full text

Oral Azacitidine in Patients With Myelodysplastic Syndrome by Shibusawa, Motoharu, Kidoguchi, Keisuke, Tanimoto, Tetsuya

Get full text

Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia by Shibusawa, Motoharu, Kidoguchi, Keisuke, Tanimoto, Tetsuya

“…In their recent study, Dr Locatelli and colleagues compared blinatumomab and standard intensive multidrug chemotherapy among children with high-risk B-cell…”
Get full text

Response-Adapted Postinduction Strategy in Follicular Lymphoma by Shibusawa, Motoharu, Kusumi, Eiji, Murakami, Jun, Tanimoto, Tetsuya

Get full text

Subcutaneous versus intravenous daratumumab in multiple myeloma by Shibusawa, Motoharu, Tanimoto, Tetsuya

Get full text

Ruxolitinib for Chronic Graft-versus-Host Disease by Gratwohl, Alois, Shibusawa, Motoharu, Zeiser, Robert, Teshima, Takanori, Locatelli, Franco

“…To the Editor: Zeiser et al. (July 15 issue) 1 report a significantly better overall response in patients treated with ruxolitinib for…”
Get full text

Long-term efficacy and safety of ruxolitinib in polycythaemia vera by Shibusawa, Motoharu, Tanimoto, Tetsuya

Get full text

Survival outcomes for extranodal natural-killer T-cell lymphoma by Shibusawa, Motoharu, Tanimoto, Tetsuya

Get full text